Skip to main content
. 2017 Mar 29;18:131. doi: 10.1186/s12891-017-1473-9

Table 2.

Bivariate correlations between accelerometer assessed sedentary behaviour patterns, light physical activity and MVPA with 10-year CVD risk, individual CVD risk factors and functional disability

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
1 Age
2 Sedentary time (min/day) .29*
3 bLPA (min/day) −.22 −.78**
4 bMVPA (min/day) −.22 −.37** .35**
5 Number of Sbreaks (number/day) −.12 −.26* .61** .03
6 Number of Sbouts (number/day) .31* .81* −.79** −.26** −.67**
7 Average time per Sbout (min) .07 .34** −.50** −.09 −.56** .45**
8 Q-risk .76** .37** −.40** −.12 −.21 .38** .20
9 bCRP (mg/L) .18 .05 −.20 −.24 −.20 .15 .09 .28*
10 bESR (mm/h) .12 .20 −.23 −.21 −.09 .21 −.01 .17 .57**
11 Fibrinogen (g/L) .25 .20 −.27* −.23 −.19 .31* .03 .29* .69** .71**
12 Total cholesterol (mmol/L) .18 .17 −.10 −.18 .04 .03 .11 .09 .10 .14 − .03
13 bHDL-C (mmol/L) .05 −.11 .27* .02 .30* −.25 −.17 −.33* −.20 −.10 −.24 .29*
14 bLDL-C (mmol/L) .15 .22 −.19 −.14 −.13 .15 .19 .19 .22 .19 .06 .86** −.09
15 bTriglycerides (mmol/L) .10 .13 −.19 −.17 −.02 .08 .17 .22 −.00 .14 .11 .33* −.24b .13
16 Syst-BP (mm HG) .53** .19 −.09 −.04 .05 .17 .04 .52** .16 .19 .17 .11 .28* −.11 .22
17 Diast-BP (mm HG) .37* .08 .15 .02 .11 .13 .01 .30* −.05 −.03 −.01 .12 .23 −.07 .22 .71**
18 bPlasma insulin (mmol/L) −.08 .05 −.11 −.21 −.08 .13 −.08 .16 .28* .35* .37* −.03 −.47** .08 .37** .10 .14
19 bPlasma glucose (mmol/L) .02 .04 −.04 .06 .05 .01 .11 .12 .06 .13 .10 .07 −.30* .12 .27* .10 .19 .51**
20 bHOMA status −.08 .06 −.09 −.17 −.02 .09 −.01 .16 .23 .30* .31* −.04 −.47** .05 .35** .06 .12 .94** .74**
21  HAQ .09 .13 −.23 −.27* −.16 .17 .06 .13 .18 .27** .23 −.04 −.03 .03 −.11 .07 .02 .26** − .04 .18

Note: * p < .05, ** p < .01, p = .05, a p = .06. b Indicates non-normally distributed data that has been log transformed for inclusion parametric statistical tests

LPA light physical activity, MVPA moderate-to-vigorous physical activity, Sbreaks sedentary breaks, Sbouts sedentary bouts, CVD cardiovascular disease, HOMA homeostatic model assessment, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, CRP C-reactive protein, ESR erythrocyte sedimentation rate, Qrisk Q-risk score, HAQ Health Assessment Questionnaire